Last update 21 Nov 2024
Olmesartan Medoxomil/Amlodipine Maleate
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Olovicar |
Target |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), VDCCs blockers(Voltage-gated calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (01 Dec 2014), |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC24H29ClN2O9 |
InChIKeyTZNOWAJJWCGILX-BTJKTKAUSA-N |
CAS Registry88150-47-4 |
View All Structures (2)
Related
4
Clinical Trials associated with Olmesartan Medoxomil/Amlodipine MaleatePharmacokinetic study of olmesartan medoxomil/amlodipine 20/5 mg tablet in Chinese healthy adult volunteers
A randomized, double-blind, double-dummy, parallel group, active controlled multi-center clinical trial to evaluate the additional efficacy and safety of Olmesartan Medoxomil/Amlodipine 20/5 mg in Chinese patients with mild or moderate essential hypertension who failed to achieve their goal with Amlodipine 5mg monotherapy
A randomized, double-blind, double-dummy, parallel group, active controlled multi-center clinical trial to evaluate the additional efficacy and safety of Olmesartan Medoxomil/Amlodipine 20/5 mg in Chinese patients with mild or moderate essential hypertension who failed to achieve their goal with Olmesartan Medoxomil 20mg monotherapy
100 Clinical Results associated with Olmesartan Medoxomil/Amlodipine Maleate
Login to view more data
100 Translational Medicine associated with Olmesartan Medoxomil/Amlodipine Maleate
Login to view more data
100 Patents (Medical) associated with Olmesartan Medoxomil/Amlodipine Maleate
Login to view more data
100 Deals associated with Olmesartan Medoxomil/Amlodipine Maleate
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Hypertension | KR | 01 Dec 2014 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 4 | 207 | lsfmcrsroh(gmofeuzlma) = jutbrpeunu njkonaszwa (kfxrgxighe, hnjgomehib - jlzehezlrk) View more | - | 02 Jul 2010 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free